Related Experiment Video
Updated: Aug 26, 2026

Mammary Epithelial Transplant Procedure
Published on: June 10, 2010
P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary
Rui-An Wang1, Abhijit Mazumdar, Ratna K Vadlamudi
1Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA.
Abstract:
Stimulation of p21-activated kinase-1 (Pak1) induces cytoskeleton reorganization and signaling pathways in mammary cancer cells. Here, we show that inhibition of Pak1 kinase activity by a dominant-negative fragment or by short interference RNA markedly reduced the estrogen receptor-alpha (ER) transactivation functions. To understand the role of Pak1 in mammary glands, we developed a murine model expressing constitutively active Thr423 glutamic acid Pak1 driven by the beta-lactoglobulin promoter. We show that mammary glands from these mice developed widespread hyperplasia associated with apocrine metaplasia and lobuloalveolar hyperdevelopment during lactation. Mammary tissues with active Pak1 also exhibited an increased activation of mitogen-activated protein kinase and stimulated transactivation functions of the ER and expression of endogenous ER target genes. Furthermore, Pak1 directly phosphorylated the activation function-2 domain of the ER at the N-terminal residue Ser305, and its mutation to Ala (S305A) abolished the Pak1-mediated phosphorylation and transactivation functions of the ER, while its mutation to glutamic acid (S305E) promoted transactivation activity of ER. These findings reveal a novel role for the Pak1-ER pathway in promoting hyperplasia in mammary epithelium.
Insights
p21-activated kinase-1 (Pak1) promotes mammary gland hyperplasia by activating the estrogen receptor-alpha (ER). Pak1 directly phosphorylates ER, enhancing its transactivation functions and leading to epithelial overgrowth.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- p21-activated kinase-1 (Pak1) is implicated in cytoskeleton organization and signaling in cancer cells.
- Estrogen receptor-alpha (ER) is a key regulator of mammary gland development and function.
Purpose of the Study:
- To investigate the role of Pak1 in mammary gland development and ER signaling.
- To elucidate the molecular mechanisms by which Pak1 influences ER activity.
Main Methods:
- Inhibition of Pak1 using dominant-negative fragments and short interference RNA.
- Development of a transgenic murine model with constitutively active Pak1.
- Analysis of mammary gland morphology, ER transactivation, and downstream gene expression.
- Site-directed mutagenesis to study Pak1 phosphorylation of ER at Ser305.
Main Results:
- Pak1 inhibition reduced ER transactivation functions.
- Constitutively active Pak1 in murine mammary glands led to hyperplasia, apocrine metaplasia, and hyperdevelopment.
- Active Pak1 increased mitogen-activated protein kinase activation and ER target gene expression.
- Pak1 directly phosphorylated ER at Ser305, a modification crucial for ER transactivation.
Conclusions:
- Pak1 plays a significant role in mammary gland hyperplasia.
- The Pak1-ER signaling pathway is a novel mechanism regulating mammary epithelial proliferation.
- Pak1-mediated phosphorylation of ER at Ser305 is a key event in promoting ER activity and mammary gland overgrowth.
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway

